Literature DB >> 24189248

First three Neisseria gonorrhoeae isolates with high-level resistance to azithromycin in Sweden: a threat to currently available dual-antimicrobial regimens for treatment of gonorrhea?

Magnus Unemo1, Daniel Golparian, Bengt Hellmark.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24189248      PMCID： PMC3910770          DOI： 10.1128/AAC.02093-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  11 in total

1.  Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations.

Authors:  L Zarantonelli; G Borthagaray; E H Lee; W M Shafer
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

2.  Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia.

Authors:  Marcus Y Chen; Kerrie Stevens; Robin Tideman; Angelo Zaia; Takehiro Tomita; Christopher K Fairley; Monica Lahra; David Whiley; Geoff Hogg
Journal:  J Antimicrob Chemother       Date:  2013-02-06       Impact factor: 5.790

3.  Transcriptional control of the mtr efflux system of Neisseria gonorrhoeae.

Authors:  K E Hagman; W M Shafer
Journal:  J Bacteriol       Date:  1995-07       Impact factor: 3.490

Review 4.  Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea.

Authors:  Magnus Unemo; Robert A Nicholas
Journal:  Future Microbiol       Date:  2012-12       Impact factor: 3.165

5.  Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada.

Authors:  Vanessa G Allen; Leo Mitterni; Christine Seah; Anuradha Rebbapragada; Irene E Martin; Colin Lee; Heather Siebert; Lynn Towns; Roberto G Melano; Donald E Low
Journal:  JAMA       Date:  2013-01-09       Impact factor: 56.272

6.  Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.

Authors:  David A Lewis; Charlotte Sriruttan; Etienne E Müller; Daniel Golparian; Lindy Gumede; Donald Fick; Johan de Wet; Venessa Maseko; Jennifer Coetzee; Magnus Unemo
Journal:  J Antimicrob Chemother       Date:  2013-02-14       Impact factor: 5.790

7.  In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatment option for gonorrhea?

Authors:  Daniel Golparian; Prabhavathi Fernandes; Makoto Ohnishi; Jörgen S Jensen; Magnus Unemo
Journal:  Antimicrob Agents Chemother       Date:  2012-02-21       Impact factor: 5.191

Review 8.  Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae.

Authors:  John W Tapsall; Francis Ndowa; David A Lewis; Magnus Unemo
Journal:  Expert Rev Anti Infect Ther       Date:  2009-09       Impact factor: 5.091

9.  Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes.

Authors:  Magnus Unemo; Oskar Fasth; Hans Fredlund; Athena Limnios; John Tapsall
Journal:  J Antimicrob Chemother       Date:  2009-03-24       Impact factor: 5.790

10.  2012 European guideline on the diagnosis and treatment of gonorrhoea in adults.

Authors:  C Bignell; M Unemo
Journal:  Int J STD AIDS       Date:  2013-02       Impact factor: 1.359
View more
  27 in total

1.  The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization.

Authors:  Magnus Unemo; Daniel Golparian; Leonor Sánchez-Busó; Yonatan Grad; Susanne Jacobsson; Makoto Ohnishi; Monica M Lahra; Athena Limnios; Aleksandra E Sikora; Teodora Wi; Simon R Harris
Journal:  J Antimicrob Chemother       Date:  2016-07-17       Impact factor: 5.790

2.  Antimicrobial resistance and molecular epidemiology using whole-genome sequencing of Neisseria gonorrhoeae in Ireland, 2014-2016: focus on extended-spectrum cephalosporins and azithromycin.

Authors:  L Ryan; D Golparian; N Fennelly; L Rose; P Walsh; B Lawlor; M Mac Aogáin; M Unemo; B Crowley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-06-07       Impact factor: 3.267

Review 3.  Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.

Authors:  Magnus Unemo; William M Shafer
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

4.  Importance of multidrug efflux pumps in the antimicrobial resistance property of clinical multidrug-resistant isolates of Neisseria gonorrhoeae.

Authors:  Daniel Golparian; William M Shafer; Makoto Ohnishi; Magnus Unemo
Journal:  Antimicrob Agents Chemother       Date:  2014-04-14       Impact factor: 5.191

5.  Analysis of Neisseria gonorrhoeae azithromycin susceptibility in the United States by the Gonococcal Isolate Surveillance Project, 2005 to 2013.

Authors:  Robert D Kirkcaldy; Olusegun Soge; John R Papp; Edward W Hook; Carlos del Rio; Grace Kubin; Hillard S Weinstock
Journal:  Antimicrob Agents Chemother       Date:  2014-12-01       Impact factor: 5.191

6.  Atypical Mutation in Neisseria gonorrhoeae 23S rRNA Associated with High-Level Azithromycin Resistance.

Authors:  Cau D Pham; Evelyn Nash; Hsi Liu; Matthew W Schmerer; Samera Sharpe; Grace Woods; Brad Roland; Karen Schlanger; Sancta B St Cyr; Jonathan Carlson; Kevin Sellers; Aaron Olsen; Ruth Sanon; Henrietta Hardin; Olusegun O Soge; Brian H Raphael; Ellen N Kersh
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

7.  In vitro activity of fosfomycin alone and in combination with ceftriaxone or azithromycin against clinical Neisseria gonorrhoeae isolates.

Authors:  Christoph Hauser; Lea Hirzberger; Magnus Unemo; Hansjakob Furrer; Andrea Endimiani
Journal:  Antimicrob Agents Chemother       Date:  2014-12-29       Impact factor: 5.191

8.  In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae.

Authors:  Lindley A Barbee; Olusegun O Soge; King K Holmes; Matthew R Golden
Journal:  J Antimicrob Chemother       Date:  2014-01-26       Impact factor: 5.790

9.  Genomic Epidemiology and Molecular Resistance Mechanisms of Azithromycin-Resistant Neisseria gonorrhoeae in Canada from 1997 to 2014.

Authors:  Walter Demczuk; Irene Martin; Shelley Peterson; Amrita Bharat; Gary Van Domselaar; Morag Graham; Brigitte Lefebvre; Vanessa Allen; Linda Hoang; Greg Tyrrell; Greg Horsman; John Wylie; David Haldane; Chris Archibald; Tom Wong; Magnus Unemo; Michael R Mulvey
Journal:  J Clin Microbiol       Date:  2016-03-02       Impact factor: 5.948

Review 10.  Antimicrobial Resistance Expressed by Neisseria gonorrhoeae: A Major Global Public Health Problem in the 21st Century.

Authors:  Magnus Unemo; Carlos Del Rio; William M Shafer
Journal:  Microbiol Spectr       Date:  2016-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.